biotech.today

Details

  • ●Modalities: proteins, enzymes, antibodies
  • ●Therapeutic areas: Undisclosed
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $24M

Key considerations

  • ●AI tools in use: Cradle Platform (SaaS)
  • ●$24M Series A (2023)
  • ●Multi-biotech customer base (Johnson Matthey, Constructive Bio, others disclosed)
  • ●Swiss/Dutch footprint
Get live updates on Cradle Bio’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Stef van Grieken

Co-Founder & CEO

ml-engineeringex-Google
Visit website →LinkedIn →